Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0022116 (
ischemia
)
91,303
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
SOD
is the main detoxifying enzyme of OFRs which have been mainly purported to participate in ischaemia revascularization lesions. A study was made of the behaviour of
SOD
during ischaemia and the response to pharmacological doses of
SOD
in Wistar rats in which ischaemia was induced by 90 min of clamping and followed by revascularization.
SOD
levels were determined in the intestinal wall, evaluating the degree of infiltration of neutrophils, leucocytes and monocytes by immunohistochemical methods.
Ischaemia
led to a significant decrease in intestinal wall
SOD
levels (p = 0.003). The administration of pharmacological doses of
SOD
was observed to improve survival of the animals (p = 0.001) and significantly decreased the infiltration of leucocytes only during revascularization measured by MPO and LCA. Beneficial effects of
SOD
could be explained by its effect as scavenger of OFRs and by its action on the neutrophil infiltration.
...
PMID:Superoxide dismutase (SOD) and neutrophil infiltration in intestinal ischaemia-revascularization. 765 5
We investigated the changes of
copper/zinc superoxide dismutase
(CuZn-SOD) and manganese superoxide dismutase (Mn-SOD) in the rat hippocampus after 10 min of cerebral ischemia induced by 4-vessel occlusion. The rats were allowed to survive for 4 h, 1 day, 3 days, and 7 days after
ischemia
. The distribution of SODs were determined by immunohistochemical staining with antibodies against rat CuZn-
SOD
and Mn-SOD. CA1 pyramidal neurons and granule cells of the dentate gyrus showed intense CuZn-
SOD
immunoreactivity, whereas CA3 and CA4 neurons showed weaker immunostaining than CA1 neurons in normal animals. The immunoreactivity was reduced by 4 h after
ischemia
in CA1, CA3, and CA4 neurons when no histological damage was observed. Mn-SOD immunostaining revealed more intense immunoreactivity in CA3 pyramidal neurons than in CA1 neurons in normal animals. Interneurons in the CA1 and CA3 regions and the dentate hilus also showed high Mn-SOD immunostaining. Although CA1 neurons lost Mn-SOD immunoreactivity by 1 day after
ischemia
, CA3 neurons and interneurons retained the immunoreactivity and preserved intact cell contour after
ischemia
. In addition, reactive glial cells, which were differentiated by immunocytochemical staining against glial fibrillary acidic protein for reactive astrocytes and histochemical staining for reactive microglial cells, were intensely stained for CuZn-
SOD
and Mn-SOD after
ischemia
.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:An immunohistochemical study of copper/zinc superoxide dismutase and manganese superoxide dismutase in rat hippocampus after transient cerebral ischemia. 769 76
In this experimental study we investigated the effect of WS-frequence spectrum physiatrics apparatus on the survival of the random flap in the back of rats. The flap was radiated vertically with the WS-apparatus for 30 minutes, twice daily for 8 days. It was found that on the ninth postoperative day, the survival areas of the radiated flaps was increased significantly (P < 0.001). The isotope (99mTc) clearance, the diaphanousflap sample and
SOD
content were examined. The results showed that WS-apparatus can reduce the production of oxygen free radicle in the flap, increase the tolerance for
ischemia
and blood supply of the flap with the proliferation and vasodilation of capillary vessels.
...
PMID:[Effect of WS-frequence spectrum physiatrics apparatus on survival of the random flap in rats]. 771 95
The cardio-protective mechanisms of EGb 761, an extract of Ginkgo biloba leaves, on myocardial ischemia-reperfusion injury were investigated using rabbits subjected to 30 minutes of regional cardiac
ischemia
and 120 min of reperfusion under anesthesia. Compared to the saline perfused group, EGb 761 treatment (10 mg/kg, injected into the coronary artery) significantly inhibited the increase in lipid peroxidation and maintained total and CuZn-
SOD
levels in both plasma and tissue during and at the end of reperfusion. Both the decrease in tissue type plasminogen activator (t-PA) and the increase in plasminogen activator inhibitor-1 (PAI-1) caused by
ischemia
-reperfusion were also significantly suppressed by EGb 761 treatment. Furthermore, the ultrastructure of the myocytes of the EGb 761 treated heart was slightly damaged after
ischemia
-reperfusion, while the control ischemic-reperfused hearts demonstrated severe histological damages such as swelling and vacuolization of the mitochondria. These results suggest that EGb 761 protects hearts by its antioxidant properties and by its ability to adjust fibrinolytic activity.
...
PMID:Efficiency of Ginkgo biloba extract (EGb 761) in antioxidant protection against myocardial ischemia and reperfusion injury. 773 27
Bromocriptine, a dopamine D2 receptor agonist, has widely been used for patients with Parkinson's disease. In this study, we examined its neuroprotective effects against neuronal damage in the CA1 subfield of the hippocampus following experimental cerebral ischemia in the Mongolian gerbil. Forebrain
ischemia
was induced by occlusion of bilateral common carotid arteries for 3 min. Bromocriptine, at a dose of 0.3 or 3 mg/kg, was injected i.p. 30 min before the onset of
ischemia
. Histopathological observations showed that neuronal damage to hippocampal CA1 neurons, which was seen 7 days after
ischemia
in vehicle-treated animals, was prevented by bromocriptine treatment. Immunohistochemical staining for
copper/zinc superoxide dismutase
and manganese superoxide dismutase decreased markedly in the CA1 neurons of vehicle-treated animals 2 days after
ischemia
when histological neuronal destruction was not yet seen, but was well preserved in bromocriptine-treated animals. The present findings show that bromocriptine protects against
ischemia
-induced neuronal damage, and that the mechanism of the neuroprotection may relate to the preservation of SODs. Bromocriptine, which was recently shown to be a potent free radical scavenger, may have a potent neuroprotective action against disorders including ischemic stroke.
...
PMID:Bromocriptine protects against delayed neuronal death of hippocampal neurons following cerebral ischemia in the gerbil. 775 51
The effects of antioxidant drugs on retinal
ischemia
-reperfusion damage were studied by electroretinograms (ERGs) from reperfused Dutch rabbit eyes. After inducing retinal
ischemia
by increasing the intraocular pressure (IOP) up to 140 mmHg for 60 minutes, the reperfusion was started by lowering the IOP to the normal level. Mannitol, polyethylene glycol superoxide dismutase (PEG-SOD), or ascorbic acid was administered by drip-infusion to the rabbits immediately after (early group) or 1 hr after (delayed group) the start of reperfusion. Saline, as a control, was administered by the same method as the early group. The a- and b-waves were recorded before the
ischemia
and during the reperfusion. In the early group treated by each drug, the recovery rates of the b-wave amplitudes at 4 hrs after the start of reperfusion were significantly greater than those in the controls. In the delayed group, the ERG recovery rate in rabbits treated with PEG-
SOD
was significantly better than in the controls. These results indicated that all these drugs were effective in protecting from the retina from the
ischemia
-reperfusion damage, and that some antioxidant drugs might be effective even when they were administered after the start of reperfusion.
...
PMID:[An electrophysiological study on the effect of antioxidant drugs against retinal ischemia-reperfusion damage]. 778 13
Our in vivo model of mesenteric
ischemia
/reperfusion (I/R) has shown that the gut serves as a priming bed for neutrophils (PMN). Activation of phospholipase A2 (PLA2) during
ischemia
temporally precedes PMN sequestration in the gut and the appearance of primed PMN in the portal circulation. Therefore, we hypothesized that reperfused gut secretes platelet activating factor (PAF) via PLA2 activation that is responsible for increased PMN chemotaxis and priming for superoxide (O2-) generation. Sprague-Dawley rats underwent gut
ischemia
/reperfusion (45 min SMA occlusion/2 hr reperfusion) or sham laparotomy. Distal ileum was harvested, rinsed with bacteriostatic saline/neomycin, and incubated for 1 hr at 37 degrees C in RPMI 1640 and the cell-free supernatant was collected. Normal human PMNs, isolated by plasma-Percoll gradients, were pretreated with or without a PAF receptor antagonist (WEB 2170). Chemotaxis toward gut supernatant was then measured by the agarose method. Additionally, PMNs were preincubated with or without WEB 2170 and their O2- release in response to 1 microM FMLP was measured by the Vmax of
SOD
-inhibitable cytochrome c reduction. Reperfused gut produced a chemotactic index of 2.1 +/- 0.1 compared to 0.2 +/- 0.9 following sham laparotomy (P < 0.05); this was reduced to 0.4 +/- 0.9 with PAF receptor blockade. Similarly, gut I/R supernatant primed PMNs for O2- (P < 0.05) compared to laparotomy, and this effect was abrogated by a PAF antagonist. These data suggest that reperfused gut can elaborate PAF which chemoattracts and primes PMNs for O2- generation.
...
PMID:Reperfused gut elaborates PAF that chemoattracts and primes neutrophils. 779 40
Oxygen free radical scavengers protect against
ischemia
/reperfusion injury of the kidney in vivo and against hypoxia/reoxygenation (H/R) injury of renal cells in several in vitro systems. In an attempt to maximize renal protection we tested several antioxidants in combination; the individual components had previously reduced reoxygenation injury of hypoxic renal epithelial cells. Both glutathione (GSH; 1 mM) and Cu,Zn-SOD provided significant protection against posthypoxic injury. Surprisingly, the combination of Cu,Zn-SOD plus GSH eliminated protection entirely and was highly toxic to normoxic cells. The toxicity of Cu,Zn-SOD+GSH was not prevented by the iron chelator deferoxamine and was only slightly reduced by the hydroxyl scavenger DMTU. Catalase reversed the toxicity of Cu,Zn-SOD+GSH and provided net protection. Direct measurement of intracellular peroxides using 2,7-dichlorofluorescein quantitated by laser cytometry also revealed enhanced generation of peroxides by cells during H/R when Cu,Zn-SOD+GSH was present. GSSG was less toxic than GSH when combined with Cu,Zn-SOD. Importantly, the combination of Mn-SOD+GSH provided superior protection to either agent alone. In the presence of added GSH, heated or autoclaved Cu,Zn-SOD was still toxic, whereas
SOD
free of chelatable Cu++ was benign. In the presence of GSH, Cu++ derived from
SOD
may promote the formation of toxic thionyl radicals, metal-centered radicals, and/or H2O2, thereby causing cell injury. Great care should be used in designing and interpreting studies employing combinations of antioxidants.
...
PMID:Hazards of antioxidant combinations containing superoxide dismutase. 779 96
A new histofluorescence method by HPAA (p-hydroxyphenyl acetic acid) for free radicals in the brain tissue was devised to study neuronal damage induced by
ischemia
. Cerebral ischemia was produced in rats by injection of plastic microspheres and arachidonic acid (AA) into the right carotid artery. The concentration of malondialdehyde (MDA; free radical) in cerebral cortex of aminotriazol (an H2O2-dependent inhibitor of catalase) treated rats 2 h after stroke was 6.33 times the level before infarction, while the concentration of MDA in h-r
SOD
(free radical-scavenging enzyme) treated rats 2 h after stroke was significantly lower than in untreated rats. The histochemical findings demonstrated marked H2O2 production around blood vessels occluded by microspheres in the cerebral cortex of the aminotriazole treated rats 2 h after stroke together with disruption of the BBB. Light microscopical findings demonstrated extensive edematous changes in the aminotriazole treated rats 2 h after stroke, while pathological damage in
SOD
treated rat brains was absent or minimal. We conclude that free radicals are formed during
ischemia
, and that AA appears to be a major source of activated oxygen radicals. The findings indicate that
SOD
is protective against
ischemia
-induced neuronal damage.
...
PMID:Histochemical demonstration of free radicals (H2O2) in ischemic brain edema and protective effects of human recombinant superoxide dismutase on ischemic neuronal damage. 797 74
We performed the present study to clarify whether lecithinized superoxide dismutase (PC-SOD) enhanced its pharmacologic potency by increasing its cell membrane affinity. PC-
SOD
, in which 4 molecules of a phosphatidylcholine (PC) derivative were covalently bound to each dimer of recombinant human CuZn-
SOD
(rhCuZn-SOD), was shown to have a high membrane affinity using a laser confocal imaging technique. PC-
SOD
efficiently scavenged superoxide anion (O2-) produced by phorbol myristate acetate (PMA)-stimulated human neutrophils (IC50 0.60 U/ml), and it exerted a dose-dependent scavenging effect (IC50 1.27 U/ml) even when the neutrophils were washed after incubation with PC-
SOD
. In contrast, neither unmodified
SOD
nor polyethylene glycol-bound
SOD
(PEG-SOD) showed a scavenging effect for washed neutrophils, even at a high concentration (100 U/ml). PC-
SOD
also showed a strong protective effect against human vascular endothelial cell damage caused by O2- generated by stimulated neutrophils, and PC-
SOD
was approximately 100-fold more potent than unmodified
SOD
(in vitro IC50 100 U/ml for PC-SOD and > 10,000 U/ml for unmodified
SOD
). Moreover, PC-
SOD
(50,000 U/kg) had an inhibitory effect on
ischemia
-reperfusion paw edema in mice, whereas neither unmodified
SOD
nor PEG-
SOD
had any effect. These results suggest that PC-
SOD
(designed to target for cell membranes) exerted a far higher pharmacologic activity by increasing cell membrane affinity than unmodified
SOD
and may be potentially useful for various clinical applications.
...
PMID:Lecithinized superoxide dismutase enhances its pharmacologic potency by increasing its cell membrane affinity. 799 83
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>